Schedule 13G ownership disclosure

Immunic Inc

Common Stock, $0.0001 par value · CUSIP: 4525EP101

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Nantahala Capital Management, LLC

    Shares: 10,378,406.00 · Class: 8.22%

  • Wilmot B. Harkey

    Shares: 10,378,406.00 · Class: 8.22%

  • Daniel Mack

    Shares: 10,378,406.00 · Class: 8.22%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-26-015336
Form type
SCHEDULE 13G/A
Filer
IMMUNIC, INC.
CIK
CIK 1280776
Filed
Feb 13, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub